TNFRSF14 and pancreatic neoplasm: Furthermore, the survival analyses of patients with pancreatic cancer clearly indicated that the expression levels of CD112 and TNFRSF14 had no significant influence on overall survival (OS) (Figure 1C and D) and disease‐free survival (DFS, also called relapse‐free survival [RFS]) (Figure 1E and F).